» Articles » PMID: 22421624

Ottawa Panel Evidence-based Clinical Practice Guidelines for Aerobic Walking Programs in the Management of Osteoarthritis

Overview
Date 2012 Mar 17
PMID 22421624
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To update the Evidence-Based Clinical Practice Guidelines (EBCPGs) on aerobic walking programs for the management of osteoarthritis (OA) of the knee.

Data Sources: A literature search was conducted using the electronic databases MEDLINE, PubMed, and the Cochrane Library for all studies related to aerobic walking programs for OA from 1966 until February 2011.

Study Selection: The literature search found 719 potential records, and 10 full-text articles were included according to the selection criteria. The Ottawa Methods Group established the inclusion and exclusion criteria regarding the characteristics of the population, by selecting adults of 40 years old and older who were diagnosed with OA of the knee.

Data Extraction: Two reviewers independently extracted important information from each selected study using standardized data extraction forms, such as the interventions, comparisons, outcomes, time period of the effect measured, and study design. The statistical analysis was reported using the Cochrane collaboration methods. An improvement of 15% or more relative to a control group contributes to the achievement of a statistically significant and clinically relevant progress. A specific grading system for recommendations, created by the Ottawa Panel, used a level system (level I for randomized controlled studies and level II for nonrandomized articles). The strength of the evidence of the recommendations was graded using a system with letters: A, B, C+, C, D, D+, or D-.

Data Synthesis: Evidence from 7 high-quality studies demonstrated that facility, hospital, and home-based aerobic walking programs with other therapies are effective interventions in the shorter term for the management of patients with OA to improve stiffness, strength, mobility, and endurance.

Conclusions: The greatest improvements were found in pain, quality of life, and functional status (grades A, B, or C+). A common limitation inherent to the EBCPGs is the heterogeneity of studies included with regards to the characteristics of the population, the interventions, the comparators, the outcomes, the period of time, and the study design. It is strongly recommended to use the Cochrane Risk of Bias Summary assessment to evaluate the methodologic quality of the studies and to consider avenues for future research on how aerobic walking programs would be beneficial in the management of OA of the hip.

Citing Articles

Evidence-based rehabilitation medicine: definition, foundation, practice and development.

Zhang J, He C Med Rev (2021). 2024; 4(1):42-54.

PMID: 38515780 PMC: 10954297. DOI: 10.1515/mr-2023-0027.


Identifying strategies that support equitable person-centred osteoarthritis care for diverse women: content analysis of guidelines.

Abuwa C, Abbaticchio A, Theodorlis M, Marshall D, MacKay C, Borkhoff C BMC Musculoskelet Disord. 2023; 24(1):734.

PMID: 37710195 PMC: 10500823. DOI: 10.1186/s12891-023-06877-x.


Association between adherence to a home exercise program and central sensitization, pain intensity, and functionality in individuals with knee osteoarthritis.

de Santana G, Dibai-Filho A, da Silva Junior J, Barbosa da Silva A, de Jesus S, Dos Santos P BMC Musculoskelet Disord. 2022; 23(1):989.

PMID: 36397008 PMC: 9669521. DOI: 10.1186/s12891-022-05959-6.


Evaluation of the Effectiveness of Iontophoresis with Perskindol Gel in Patients with Osteoarthritis of the Knee Joints.

Dakowicz A, Dzieciol-Anikiej Z, Hryniewicz A, Judycka M, Ciolkiewicz M, Moskal-Jasinska D Int J Environ Res Public Health. 2022; 19(14).

PMID: 35886341 PMC: 9315835. DOI: 10.3390/ijerph19148489.


Location-Dependent Human Osteoarthritis Cartilage Response to Realistic Cyclic Loading: Analysis on Different Knee Compartments.

Assirelli E, Caravaggi P, Mazzotti A, Ursini F, Leardini A, Belvedere C Front Bioeng Biotechnol. 2022; 10:862254.

PMID: 35782520 PMC: 9240619. DOI: 10.3389/fbioe.2022.862254.